Lower-Dosage Acute Peritoneal Dialysis versus Acute Intermittent Hemodialysis in Acute Kidney Injury

医学 急性肾损伤 腹膜透析 血液透析 随机对照试验 败血症 透析 置信区间 相对风险 外科 内科学
作者
Watanyu Parapiboon,Sajja Tatiyanupanwong,Kamol Khositrangsikun,Thanawat Phulkerd,Piyanut Kaewdoungtien,Watthikorn Pichitporn,Nuttha Lumlertgul,Sadudee Peerapornratana,Fangyue Chen,Nattachai Srisawat
出处
期刊:Clinical Journal of The American Society of Nephrology [Lippincott Williams & Wilkins]
卷期号:19 (8): 970-977 被引量:9
标识
DOI:10.2215/cjn.0000000000000482
摘要

Key Points The efficacy of acute peritoneal dialysis is still controversial. There was no significant difference in 28-day mortality between acute peritoneal dialysis and intermittent hemodialysis. Background Lower delivered dose of acute peritoneal dialysis (PD) in AKI requires less resources but raises concerns regarding adequate solute and water clearance. The relative merits of lower-dose PD versus intermittent hemodialysis remain uncertain. Methods A multicenter randomized controlled trial compared the outcomes between acute lower-dosage PD (18–24 L per day) and intermittent hemodialysis (three times per week) from May 2018 to January 2021 in patients with AKI. The primary outcome was 28-day mortality rate. Secondary outcomes included 28-day dialysis-free survival and kidney recovery, metabolic profile, and procedure-related complications. Noninferiority of PD to hemodialysis would be demonstrated if the upper bound of the 95% confidence interval ( CI) on risk difference (PD-hemodialysis) in 28-day mortality rates between the two groups was <20%. Results We included 157 patients (80 allocated to PD and 77 to intermittent hemodialysis). Before KRT initiation, baseline clinical characteristics between groups were comparable. The overall mean age was 57±15 years. The most frequent cause of AKI was sepsis (68%). There was no difference in 28-day mortality between acute PD and intermittent hemodialysis (50% versus 49%, risk difference 0.6 [95% CI, −15.0 to 16.3]), and 28-day dialysis-free survival (42% versus 37%, risk difference 4.6 [95% CI, −11.1 to 20.3]). Mean weekly Kt/V urea was 2.11±1.14 and 2.55±1.11 in the PD and intermittent hemodialysis groups, respectively. The 7-day fluid balance of PD and intermittent hemodialysis patients was not significantly different. There was more frequent intradialytic hypotension in the intermittent hemodialysis group and more frequent hypokalemia in the PD group. Conclusions In this study of patients with AKI, there was no significant difference in 28-day mortality between acute PD and intermittent hemodialysis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zip666完成签到 ,获得积分10
1秒前
缥缈夏彤完成签到,获得积分10
2秒前
之埃里克说完成签到 ,获得积分10
2秒前
feifei完成签到,获得积分10
4秒前
涛涛完成签到,获得积分10
4秒前
果冻完成签到 ,获得积分10
6秒前
典雅的纸飞机完成签到 ,获得积分10
7秒前
大模型应助eweawe采纳,获得10
7秒前
Bingo完成签到,获得积分10
7秒前
ElaineXU完成签到 ,获得积分10
9秒前
去码头整点薯条完成签到 ,获得积分10
14秒前
CandyJump完成签到,获得积分10
15秒前
我小怂怂006完成签到 ,获得积分10
18秒前
珠珠完成签到 ,获得积分10
20秒前
森莫莓完成签到,获得积分10
21秒前
24秒前
26秒前
铃铛完成签到 ,获得积分10
27秒前
追梦完成签到,获得积分10
29秒前
Hello应助Zyra采纳,获得50
31秒前
长情的向真完成签到 ,获得积分10
34秒前
40秒前
yqt完成签到,获得积分10
46秒前
zzz完成签到,获得积分10
48秒前
大个应助科研通管家采纳,获得30
49秒前
Orange应助科研通管家采纳,获得10
49秒前
丘比特应助科研通管家采纳,获得10
50秒前
科研通AI2S应助科研通管家采纳,获得10
50秒前
Hello应助科研通管家采纳,获得10
50秒前
明理念双完成签到 ,获得积分10
51秒前
Sue完成签到 ,获得积分10
52秒前
南瓜好吃完成签到 ,获得积分10
52秒前
53秒前
六月完成签到,获得积分20
54秒前
蔡晓华完成签到,获得积分10
54秒前
55秒前
Jason完成签到 ,获得积分10
56秒前
六月发布了新的文献求助10
57秒前
吃瓜米吃瓜米完成签到 ,获得积分10
58秒前
名字有点甜诶完成签到 ,获得积分10
59秒前
高分求助中
The Graphene Handbook (2019 Edition) 800
IEST-RP-CC018: Cleanroom Cleaning and Sanitization: Operating and Monitoring Procedures 600
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
久松真一著作集〈第5巻〉禅と芸術 500
Fundamentals of Modern Mathematics: A Practical Review (Dover Books on Mathematics) 500
Cold War Transcended: Australia's China Policy, 1949-1990 470
Comprehensive Organic Synthesis 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6594692
求助须知:如何正确求助?哪些是违规求助? 8365267
关于积分的说明 17907335
捐赠科研通 5745312
什么是DOI,文献DOI怎么找? 2952465
邀请新用户注册赠送积分活动 1927813
关于科研通互助平台的介绍 1820354